NKTR CIK: 906709

Nektar Therapeutics

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.80
FY22:
0.55
FY23:
0.33
FY24:
0.26
FY25:
0.27
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.32
FY22:
0.16
FY23:
0.07
FY24:
0.04
FY25:
0.01
Total assets
Change from FY21 to FY25
billions USD
FY21:
1.12
FY22:
0.71
FY23:
0.40
FY24:
0.30
FY25:
0.28

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.09
FY22:
0.07
FY23:
0.05
FY24:
0.06
FY25:
0.05
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.35
FY22:
0.28
FY23:
0.22
FY24:
0.18
FY25:
0.14
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.68
FY22:
0.37
FY23:
0.13
FY24:
0.06
FY25:
0.09
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
1.12
FY22:
0.71
FY23:
0.40
FY24:
0.30
FY25:
0.28

All amounts in billions USD Data source:SEC EDGAR